All Stories

  1. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models

    Article • The Prostate, August 2018, Wiley

    Zoran Culig

  2. The way towards understanding possible multiple functions of AR V7 in prostate cancer

    Article • BJU International, August 2018, Wiley

    Zoran Culig

  3. Oncolytic activity of the rhabdovirus VSV-GP against prostate cancer

    Article • International Journal of Cancer, July 2018, Wiley

    Zoran Culig

  4. Olaparib is effective in combination with, and as maintenance therapy after, first-line endocrine therapy in prostate cancer cells

    Article • Molecular Oncology, March 2018, Wiley

    Zoran Culig

  5. Interleukin-4 induces a CD44high /CD49bhigh PC3 subpopulation with tumor-initiating characteristics

    Article • Journal of Cellular Biochemistry, January 2018, Wiley

    Zoran Culig

  6. Predictive and prognostic role of serum neopterin and tryptophan breakdown in prostate cancer

    Article • Cancer Science, April 2017, Wiley

    Zoran Culig, PhD Dietmar N Fuchs

  7. The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer

    Article • Molecular Oncology, January 2017, Wiley

    Zoran Culig

  8. The AR/NCOA1 axis regulates prostate cancer migration by involvement of PRKD1

    Article • Endocrine Related Cancer, June 2016, Bioscientifica

    Zoran Culig

  9. New possibilities for urinary molecular diagnostics

    Article • BJU International, March 2016, Wiley

    Zoran Culig

  10. Androgen Receptor Coactivators in Regulation of Growth and Differentiation in Prostate Cancer

    Article • Journal of Cellular Physiology, October 2015, Wiley

    Zoran Culig

  11. Is Eotaxin-1 a serum and urinary biomarker for prostate cancer detection and recurrence?

    Article • The Prostate, August 2015, Wiley

    Zoran Culig

  12. Targeting Interleukin-6 for the Treatment of Castration-Resistant Prostate Cancer

    Article • April 2014, Bentham Science Publishers

    Zoran Culig

  13. SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer

    Article • November 2013, Bioscientifica

    Zoran Culig

  14. IL6 sensitizes prostate cancer to the antiproliferative effect of IFN 2 through IRF9

    Article • August 2013, Bioscientifica

    Zoran Culig

  15. Current mouse and cell models in prostate cancer research

    Article • April 2013, Bioscientifica

    Zoran Culig

  16. Rapidly changing endocrine oncology research: personal reflection of the past, present and future times

    Article • November 2012, Bioscientifica

    Zoran Culig

  17. Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways

    Article • March 2012, Bioscientifica

    Zoran Culig